Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis

ConclusionThis retrospective study demonstrates that chronic low-dose IVIg treatment in patients with MG improves clinical outcomes and has a prolonged and significant steroid-sparing effect over a period of 3  years.
Source: Journal of Neurology - Category: Neurology Source Type: research